Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

526
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
526
Vaccinations01:51

Vaccinations

46.8K
Overview
46.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing Gastrointestinal Transit Time Alters Microbiome Composition and Bile Acid Metabolism: A Cross-Over Study in Healthy Volunteers.

Neurogastroenterology and motility·2025
Same author

Further Insights into the Measurement of Free Polysaccharide in Meningococcal Conjugate Vaccines.

Vaccines·2025
Same author

<i>Salmonella</i> Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses.

Science immunology·2021
Same author

Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use.

Pathogens (Basel, Switzerland)·2021
Same author

Evidence of Extended Thermo-Stability of Typhoid Polysaccharide Conjugate Vaccines.

Microorganisms·2021
Same author

Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component <i>Shigella</i> GMMA-Based Vaccines.

Microorganisms·2021
Same journal

Correction: Peptine et al. Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) and Vancomycin-Resistant Enterococci (VRE) in Nosocomial Infections: A Systematic Review of Resistance, Pathogenesis, and Clinical Management. <i>Microorganisms</i> 2026, <i>14</i>, 428.

Microorganisms·2026
Same journal

Torque Teno Virus (TTV) Plasma Load and Immune Reconstitution in People Living with HIV: A Systematic Review.

Microorganisms·2026
Same journal

Optimizing Bacteriophage Screening and Isolation Methods for Microbial Samples Derived from Different Body Sites of Cattle.

Microorganisms·2026
Same journal

Enhanced Biphenyl Degradation by <i>Rhodococcus</i> sp. TG-1 Under Cr(VI) Stress via Modified Biochar Immobilization.

Microorganisms·2026
Same journal

In Vitro Detection of Biologically Active Staphylococcal Enterotoxins Type B and C1 as an Alternative to In Vivo Testing.

Microorganisms·2026
Same journal

Monitoring Hygiene Protocols and Exploring Alternatives to Counteract Resistant Pathogens: A Case Study from Southern Italy on Healthcare-Associated Infection Control.

Microorganisms·2026
See all related articles

Related Experiment Video

Updated: Oct 22, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.2K

Recent Developments in Enteric Bacterial Vaccines.

Sjoerd Rijpkema1, Barbara Bolgiano1

  • 1The National Institute for Biological Standards and Control (NIBSC), South Mimms EN6 3QG, UK.

Microorganisms
|August 27, 2021
PubMed
Summary
This summary is machine-generated.

This issue highlights advancements in bacterial enteric vaccines, focusing on innovative strategies to combat gastrointestinal infections. These developments offer new hope for improved public health through effective immunization.

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Related Experiment Videos

Last Updated: Oct 22, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.2K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Area of Science:

  • Microbiology and Immunology
  • Vaccine Development
  • Infectious Diseases

Background:

  • Bacterial enteric infections pose a significant global health burden, particularly in developing nations.
  • Current vaccine options for common enteric pathogens remain limited or suboptimal.
  • There is a critical need for novel and effective vaccines against diarrheal diseases.

Discussion:

  • Exploration of novel vaccine platforms, including subunit, conjugate, and live-attenuated approaches.
  • Focus on key enteric pathogens such as Salmonella, Shigella, ETEC, and Vibrio cholerae.
  • Strategies for enhancing immunogenicity and durability of vaccine responses.

Key Insights:

  • Recent progress in understanding pathogen-host interactions is driving rational vaccine design.
  • Promising preclinical and early clinical data for several candidate vaccines.
  • Development of innovative delivery systems to improve vaccine efficacy and accessibility.

Outlook:

  • Potential for licensure of new bacterial enteric vaccines in the coming years.
  • Impact of these vaccines on reducing morbidity and mortality from diarrheal diseases.
  • Future research directions, including combination vaccines and universal enteric vaccines.